Resistance NSCLC - Globe Thesis

Keyword [Resistance NSCLC] Result: 1 - 20 \| Page: 1 of 1
1.	The Role Of M2 MAChR In The Malignant Phenotype Of NSCLC And The Underlying Signaling Pathway
2.	Mechanism Of Hedgehog Signaling Pathway In EGFR-TKI Sensitive And Resistance NSCLC Cells
3.	A Study Of Influence And Mechanism Of Constitutively Active STAT3on Gefitinib Resistance In NSCLC Cells
4.	Study Of Pan-HER Inhibitoralone Or Combination On Resistance Non-small Cell Lung Cancer H1975Cell In Vitro
5.	The Mechanism Of C-MET Signal Pathway,Which Is Involved In HGF Induced Non-small Cell Lung Cancer Cells To Erlotinib Resistance
6.	Study On The Correlation Between NRP1 And MiR-9 Expression In NSCLC And Their Roles In Radiation Resistance
7.	The Clinical Study Of Xiaoji Decotion Combined With Erlotinib In The Treatment Of Non-Small Cell Lung Cancer
8.	A Novel Camptothecin Analogue FL118 Shows Effectively Inhibition On Cisplatin Resistance Non-small Cell Lung Carcinoma
9.	Receproal Positive Regulation Between Cx26 And PI3K/Akt Pathway Confers Acquired Gefitinib Resistance In NSCLC Cells Via Gjic-independent Induction Of EMT
10.	Inhibition Of FoxO3a On The Tumorigenesis In NSCLC By Down-regulating EPS8 Directly
11.	Profiles And Bioinformatics Analyses Of CircRNAs In Taxol-resistant NSCLC
12.	Effect Of FoxO3a On Gefitinib Resistance By Inhibiting PDK4 In PC9 Cells
13.	The Association Between BIM Deletion Polymorphism And Therapeutic Efficacy In Advanced EGFR T790M NSCLC With Osimertinib
14.	Establ Ishment Of An Osimertinib-resi Stant Cell Line Of Human Non-small Cell Lung Cancer And The Subsequent Sensitivity Of Themotherapeutic Drugs
15.	Establishment Of The Third Generation EGFR-TKI AZD9291 Drug-resistance NSCLC Cell Lines In Vitro
16.	JQ1 Downregulates Met Expression And Inhibits The Growth Of Non-small Cell Lung Carcinoma Cells
17.	Effect Of CircPAPPA On Pemetrexed-resistance Non-small Cell Lung Cancer
18.	GBP1 Promotes Erlotinib Resistance Via PGK1-activated EMT Signaling In Non-small Cell Lung Cancer
19.	Evolution Of Immune Microenvironment And Mechanism Of Drug Resistance In EGFR L858R/T790M Co-mutant Non-small Cell Lung Cancer With Osimertinib Treatment
20.	The Study On GSDME-mediated Pyroptosis Enhancing The Sensitivity Of Cisplatin To Kill Non-small Cell Lung Cancer
<<First <Prev Next> Last>> Jump to